Skip to main content

Affomix, U Montreal PGx Centre, and Montreal Heart Institute Ink PGx Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Antibody company Affomix today announced a collaboration with the University of Montreal Pharmacogenomics Centre and the Montreal Heart Institute to develop companion diagnostic biomarkers for cardiovascular disease.

Under the agreement, the financial terms of which were not disclosed, Affomix and the PGx Centre will partner to develop reagents for the quantitative profiling of candidate biomarkers in a multiplex manner. The PGx Centre has identified a panel of proteins it believes may be predictive of patient response to novel anti-atherosclerotic agents.

In a statement, Jean-Claude Tardif, director of the Research Center at the Montreal Heart Institute, said, "Having the ability to consistently measure these cardiovascular proteins represents a key first step in identifying important biomarkers that will help us better understand atherosclerosis and how patients respond to certain medications."

Based in Branford, Conn., Affomix develops monoclonal antibodies using its proprietary technology, called Y2H Express, that it says improves upon traditional yeast two-hybrid technology in terms of antibody specificity.

In January, Affomix and the City of Hope announced a collaboration to determine the clinical use of "digital proteomics" using next-generation sequencing. In December, it signed an agreement with Kalgene Pharmaceuticals to select antibodies with potential diagnostic and therapeutic use in breast cancer.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.